Aug. 12 - Biocan's Arun Chandavarkar says the Indian company -- now valued at $1 billion -- is at work developing a new form of insulin.
Click to begin watching: Biotech Power
SearchismsA search oriented blog
This is project is in beta. All information is general in nature and provided for educational purposes only, it is not intended to be used as a substitute for appropriate professional advice. webmaster@broadcast.organicframework.com : partners : partner highlights : site map : all links : content management software